Cravath and Kirkland ride pharma wave to win places on $5.8bn Abbott-Alere deal Legal Business1 February 2016Corporate and M&A Already two of the big winners from the merger bonanza in the pharmaceuticals sector, Cravath, Swaine & Moore and Kirkland & Ellis have won mandates advising on the $5.8bn purchase of diagnostic testing company Alere by Abbott Laboratories.Your limit of 1 article in 30 days is up. Please login for full access or subscribe. Corporate users - click here for simple access (no password needed). For more information, please contact [email protected] Related ContentMore in this categoryBeyond the deals: how clients rate London’s top M&A teams‘The energy capital of the world’ – why the global and US elite are betting on HoustonRopes and Kirkland lead on EQT’s $3.7bn acquisition of secondaries leader CollerBeyond the deals: how clients rate London’s top M&A teamsFreshfields and Slaughters among international line-up on €5bn Deutsche Börse dealRopes and Kirkland lead on EQT’s $3.7bn acquisition of secondaries leader CollerRevolving doors: Simpson Thacher, Latham, Sidley lead New Year London movesFive partners vie to succeed Hoyland as Simmons managing partner‘Seize every opportunity’ – Paul Hastings partner Reena Gogna on City law, Suits and poetry